Gilead Secures FDA Approval for Bixlenvo, First Single‑Tablet HIV Regimen for Suppressed Adults

SentiSense · Published Aug 28, 2026, 10:26 AM ET · Updated Aug 28, 2026, 1:54 PM ET

The U.S. Food and Drug Administration has approved Bixlenvo, a once‑daily HIV pill from Gilead Sciences. The tablet combines bictegravir with lenacapa...